CM
WST icon

Churchill Management’s West Pharmaceutical WST Stock Holding History

Churchill Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,323
Closed -$4.48M – 164
2024
Q1 		$4.48M Sell
11,323
-122
-1% -$45.1K 0.06% 109
2023
Q4 		$4.03M Sell
11,445
-269
-2% -$95.2K 0.06% 101
2023
Q3 		$4.4M Buy
11,714
+173
+1% +$66.9K 0.07% 100
2023
Q2 		$4.41M Buy
+11,541
New +$4.12M 0.07% 100

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Churchill Management's WST Position: Q2 2024 in Review

Churchill Management sold out of West Pharmaceutical (WST) in Q2 2024, closing a stake of 11,323 shares — an estimated $4.48M sold.

Churchill Management first reported a position in WST in Q2 2023 and held it in 4 quarters. The position peaked at $4.48M in Q1 2024. 777 funds tracked by Wall St. Rank hold WST as of Q2 2024.

  • Churchill Management reported no remaining West Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Churchill Management sold 11,323 West Pharmaceutical shares in Q2 2024, an estimated $4.48M.
  • Churchill Management first reported a position in West Pharmaceutical in Q2 2023 and held it in 4 quarters.
  • Churchill Management's West Pharmaceutical position peaked at $4.48M in Q1 2024.
  • 777 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on Churchill Management's 13F filing for Q2 2024, filed 22 Jul 2024.